The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...

The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

However, data from clinical trials when the vaccines were first released showed that the Pfizer vaccine was 95% effective at preventing COVID-19, while the Moderna vaccine was 94.1% effective.

Pfizer did not say that its vaccine had "95% efficacy against infection." In Pfizer's clinical trial cohort, of the 170 confirmed cases of COVID-19, 162 were in the placebo group versus eight in ...